{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.56","meta":{"versionId":"6","lastUpdated":"2023-04-03T14:03:56.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.56","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.56"}],"version":"20150714","name":"HER2NEUTest","title":"HER2 NEU test","status":"active","experimental":false,"date":"2015-07-14T01:00:00-04:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"444711007","display":"Measurement of total human epidermal growth factor receptor 2 using reverse phase protein microarray technique (procedure)"}]}]},"expansion":{"identifier":"urn:uuid:9bb87d6e-0df5-4e39-b1e9-f385b116b788","timestamp":"2023-12-10T21:42:42-05:00","total":1,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"444711007","display":"Measurement of total human epidermal growth factor receptor 2 using reverse phase protein microarray technique (procedure)"}]}}